AI-generated summary
The authors report a randomized, double-blind crossover trial of 57 Japanese outpatients with mild depression who wore active or placebo 40-Hz violet light goggles for 4 weeks. Active goggles were associated with greater improvement on the Montgomery-Åsberg Depression Rating Scale than placebo, with no related adverse events reported. The authors describe the goggles as possibly effective, but the study's small size and single-clinic setting limit how far this can be generalized.
- Participants
- 57
- Who or what was studied
- 57 Japanese outpatients aged 20-74 years with mild major depressive disorder
- Limits stated in the abstract
- The abstract reports a single clinic setting and a modest sample, so generalizability and the strength of the finding are uncertain.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Photobiomodulation therapy, Photobiomodulation, Confidence interval, Placebo-controlled, Trial registration, Neuromodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.